Form 4: Pediatrix Medical Group Executive Receives Stock Grant

Kasandra H. Rossi, EVP, CFO and Treasurer of Pediatrix Medical Group, Inc., received 11,112 shares of restricted stock as part of an annual equity award.

Summary

• Kasandra H. Rossi, the EVP, CFO and Treasurer of Pediatrix Medical Group, Inc., received 11,112 shares of restricted common stock on December 1, 2024.
• The shares were granted as part of the company's Amended and Restated 2008 Incentive Compensation Plan.
• The restricted shares will vest in three tranches: 25% on June 1, 2025, 25% on June 1, 2026, and 50% on June 1, 2027.
• Following this transaction, Ms. Rossi beneficially owns 54,869 shares of Pediatrix Medical Group, Inc.

Sentiment

Score: 7

Explanation: The document reflects a routine executive compensation event, which is generally positive for aligning management with shareholder interests. There are no negative implications.

Positives

• The stock grant aligns the executive's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Future Outlook

The document does not contain any forward-looking statements or guidance.

Industry Context

Stock grants are a common form of executive compensation in publicly traded companies, aligning management's interests with those of shareholders. This grant is part of Pediatrix Medical Group's standard compensation practices.

Comparison to Industry Standards

• Stock grants are a standard practice for executive compensation across various industries, including healthcare.
• Companies like HCA Healthcare and Tenet Healthcare also use similar equity-based compensation plans for their executives.
• The vesting schedule of 25%, 25%, and 50% over three years is a fairly typical approach to ensure long-term alignment.

Stakeholder Impact

• The stock grant aligns the executive's interests with those of the shareholders, potentially leading to better performance.
• The vesting schedule encourages long-term commitment from the executive, which can benefit the company and its stakeholders.

Key Dates

Keywords

stock grant, restricted stock, equity award, executive compensation, Pediatrix Medical Group, insider trading, vesting